Michael E. Farkouh - Concepedia

Author

Michael E. Farkouh

Also Known As

Angus, Derek C, Farkouh, Michael E, Farkouh, Michael E., German Briceo, J Woolley, M E Farkouh, M Farkouh, M. E Farkouh, M. E. Farkouh, M. Farkouh

672

Publications

30.1K

Citations

H-Index

168

Concepts

All Affiliations

University of Toronto Icahn School of Medicine at Mount Sinai Heart and Stroke Foundation University Health Network University of Alabama at Birmingham

About

Michael E. Farkouh is an author at University of Toronto specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	99	8.2K
2	Health Sciences	10	10	1.5K
3	Education	3	3	374
4	Engineering	2	2	47
5	Language Studies	1	1	84

Michael E. Farkouh

197

Publications

18K

Citations

H-Index

Page 1

	Year	Citations
Strategies for Multivessel Revascularization in Patients with Diabetes Michael E. Farkouh, Michaël Domanski, Lynn A. Sleeper, New England Journal of Medicine	2012	1.9K
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease Subodh Verma, C. David Mazer, Andrew T. Yan, Circulation	2019	550
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial Zahi A. Fayad, Venkatesh Mani, Mark Woodward, The Lancet Vascular DiseaseVascular ImageHealth SciencesCardiovascular DiseaseMedical Imaging	2011	525
A Clinical Trial of a Chest-Pain Observation Unit for Patients with Unstable Angina Michael E. Farkouh, Peter A. Smars, Guy S. Reeder, New England Journal of Medicine	1998	519
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial Michael E. Farkouh, Howard S. Kirshner, Robert A. Harrington, The Lancet Rheumatoid DisorderRheumatologyAnti-inflammatoryCardiovascular OutcomesGastrointestinal Event Trial	2004	490
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 Girish N. Nadkarni, Anuradha Lala, Emilia Bagiella, Journal of the American College of Cardiology ThrombosisCovid-19 PandemicHematologyCoagulopathyCovid-19 Epidemiology	2020	479
Atherosclerosis Inflammation Imaging with <sup>18</sup>F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations James H.F. Rudd, Kelly S. Myers, Sameer Bansilal, Journal of Nuclear Medicine	2008	438
18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible James H.F. Rudd, Kelly S. Myers, Sameer Bansilal, Journal of the American College of Cardiology InflammationPositron Emission TomographyVascular DiseaseHealth SciencesMedical Imaging	2007	417
Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation Ahmed Tawakol, Zahi A. Fayad, Robin Mogg, Journal of the American College of Cardiology InflammationCardiovascular DiseasePharmacologyInflammatory MarkerHyperlipidemia	2013	402
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention Naveen L. Pereira, Michael E. Farkouh, Derek So, JAMA	2020	389

Page 1